Effects on subclinical heart failure in type 2 diabetic subjects on liraglutide treatment versus glimepiride both in combination with metformin
About this project
Project information
A randomized controlled trial were individuals with type 2 diabetes and sublinical heartfailure are being treated with metformin plus liraglutide or metformin plus glimiperide during 3 months. Primary outcome change in left ventricular diastolic function.
